MediPost hits limit on Japan valuation...Hyundai Bio rallies[K-Bio Pulse] 송영두 2026.01.28 오전 08:00 BL Pharmtech Hits Upper Limit on Expectations for Molecular Glue Technology License Out[K-bio pul... 신민준 2026.01.16 오전 08:00 HyundaiBio·HyundaiADM First to Identify Penetrium Pseudo Resistance Research Accepted by AACR 신민준 2025.08.29 오후 12:25 Hyundai Bio Hits Limit-Up, HLB Life Science Climbs on FDA NDA Plan[K-Bio Pulse] 송영두 2025.07.13 오전 09:50 HyundaiBio begins global trials of universal antiviral drug 유진희 2025.04.23 오후 04:28 로딩중..